Dental Imaging Market to Exceed Market Valuation of USD 6.71 Billion by 2031 | SkyQuest Technology Read more
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab) Read more